If you’re a Masters degree holder and seeking Fully Funded PhD Programs, University of Plymouth, United Kingdom has several online applications open for PhD programs. Explore the PhD opportunities across diverse research areas and submit your application soon.
1. Fully Funded PhD Position in Investigating the role of eye movement in scleral growth
Summary of PhD Program:
Are you fascinated by how our eyes work and eager to make a difference in the fight against vision problems? Join our research team and help develop a revolutionary model to understand the impact of eye movements on eye health, with a focus on myopia (nearsightedness).
Application Deadline: 30 September 2024
2. Fully Funded PhD Position in Combination of cellular and metabolic therapy for meningioma treatment
Summary of PhD Program:
Tumour progression requires a metabolic rewiring of cancer cells, providing enough energy for metabolism and cellular growth increasing the fitness of cancer cells for proliferation and survival1. Meningiomas are the most common brain tumours, classified by the World Health Organization (WHO) according to aggressiveness and recurrence as grade 1 (frequency 80–85%), 2 atypical (frequency 15-20%), and 3 anaplastic (frequency 1–2%)2. There is a lack of effective systemic treatment for meningiomas, in part due to the absence of mechanistic targets. An observed rewiring in brain tumours is the modulation of metabolism, enhancing glucose uptake and usage of different energy sources such as lipids, amino acids, and lactate3–5.
Application Deadline: 12 August 2024
Follow us for daily updates!
Telegram
3. Fully Funded PhD Position in Recreating brain tumours using patient-derived glioma stem cells hosted by normal brain cells to gain novel insights into tumourigenesis
Summary of PhD Program:
Glioblastoma remains as an incurable brain tumour, with a median survival of 15 months. Major reasons for treatment failure include tumour heterogeneity, extensive infiltrative behaviour and the glioma stem cells (GSC), a subpopulation of tumours able to reform all tumour masses. These clinically relevant properties are not always recapitulated with traditional in vitro models, likely contributing to low success of clinical trials and highlighting the need for more translatable systems. Cerebral organoids, or mini-brains, are one of the most promising advances providing a physiological 3D substrate for glioma stem cells (GSC) to generate tumours that more closely mirror patient’s GBMs.
Application Deadline: 12 August 2024
